Interpace Biosciences Management
Management criteria checks 4/4
Interpace Biosciences' CEO is Tom Burnell, appointed in Dec 2020, has a tenure of 3.42 years. total yearly compensation is $678.41K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 1.87% of the company’s shares, worth $118.69K. The average tenure of the management team and the board of directors is 2.3 years and 4.3 years respectively.
Key information
Tom Burnell
Chief executive officer
US$678.4k
Total compensation
| CEO salary percentage | 64.2% |
| CEO tenure | 3.4yrs |
| CEO ownership | 1.9% |
| Management average tenure | 2.3yrs |
| Board average tenure | 4.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$1m |
| Dec 31 2023 | US$678k | US$436k | US$1m |
| Sep 30 2023 | n/a | n/a | -US$1m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$634k | US$434k | -US$6m |
| Sep 30 2022 | n/a | n/a | -US$6m |
| Jun 30 2022 | n/a | n/a | -US$6m |
| Mar 31 2022 | n/a | n/a | -US$4m |
| Dec 31 2021 | US$588k | US$425k | -US$7m |
| Sep 30 2021 | n/a | n/a | -US$13m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$24m |
| Dec 31 2020 | US$935k | US$35k | -US$29m |
Compensation vs Market: Tom's total compensation ($USD678.41K) is about average for companies of similar size in the US market ($USD661.49K).
Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.
CEO
Tom Burnell (60 yo)
3.4yrs
Tenure
US$678,407
Compensation
Dr. Thomas W. Burnell, also known as Tom, Ph.D. serves as the President, Chief Executive Officer and Director at Interpace Biosciences, Inc. since December 01, 2020 and serves as its Chairman from February...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.4yrs | US$678.41k | 1.87% $ 118.7k | |
| Chief Financial Officer | 1.1yrs | US$332.04k | 0.70% $ 44.4k | |
| Chief Scientific Officer | no data | no data | no data | |
| Chief Revenue Officer | 2.3yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| VP & Corporate Controller | 14.9yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Management: IDXG's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.4yrs | US$678.41k | 1.87% $ 118.7k | |
| Independent Director | 8.3yrs | US$50.00k | 0.040% $ 2.6k | |
| Independent Director | 19.7yrs | US$62.50k | 0.056% $ 3.6k | |
| Independent Director | 2.3yrs | US$50.00k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$40.00k | 0% $ 0 |
4.3yrs
Average Tenure
69yo
Average Age
Experienced Board: IDXG's board of directors are considered experienced (4.3 years average tenure).